MAP4K4 and central nervous system cancer: LINC01127, in collaboration with Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4), activates the JNK pathway to enhance the communication with the NF-κB pathway, culminating in the augmentation of the migratory capabilities and the self-renewal rate of glioma stem cells (GSCs) [151].